0000873303-12-000008.txt : 20120425
0000873303-12-000008.hdr.sgml : 20120425
20120425172354
ACCESSION NUMBER: 0000873303-12-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120424
FILED AS OF DATE: 20120425
DATE AS OF CHANGE: 20120425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaye Edward M. MD
CENTRAL INDEX KEY: 0001522780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 12780561
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVI BIOPHARMA INC
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-04-24
0
0000873303
AVI BIOPHARMA INC
AVII
0001522780
Kaye Edward M. MD
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
0
1
0
0
SVP & Chief Medical Officer
Stock Option (right to buy)
0.9
2012-04-24
4
A
0
68110
0
A
2022-04-24
Common Stock
68110
68110
D
This option is exercisable at the rate of 25% of the shares on April 24, 2013 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on April 24, 2016.
By: Michael Jacobsen For: Edward M. Kaye
2012-04-25
EX-24
2
ex-24.txt
EDGAR SUPPORTING DOCUMENT
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of
AVI BioPharma, Inc. (the Company), hereby constitutes
and appoints each of Michael Jacobsen and Wilson
Sonsini Goodrich & Rosati, P.C. the undersigneds true
and lawful attorney in fact to:
1. complete and execute Forms ID, 3,4 and 5 and
other forms and all amendments thereto as such attorney
in fact shall in his or her discretion determine to be
required or advisable pursuant to Section 16 of the
Securities Exchange Act of 1934 (as amended) and the
rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of
the undersigneds ownership, acquisition
or disposition of securities of the Company; and
2. do all acts necessary in order to file such forms
with the Securities and Exchange Commission, any securities
exchange or national association, the Company and such
other person or agency as the attorney in fact shall
deem appropriate. The undersigned hereby ratifies and
confirms all that said attorney in fact and agents shall
do or cause to be done by virtue hereof. The undersigned
acknowledges that each foregoing attorney in fact, in
serving in such capacity at the request of the undersigned,
is not assuming, nor is the Company assuming, any of the
undersigneds responsibilities to comply with Section 16
of the Securities Exchange Act of 1934 (as amended).
This Power of Attorney revokes any previously executed
powers of attorney and shall remain in full force and
effect until the undersigned is no longer required to
file Forms ID, 3, 4 and 5 with respect to the undersigneds
holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a
signed writing delivered to the Company and each foregoing
attorney in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 25th day of April, 2012.
Signature /s/ Edward M. Kaye
Edward M. Kaye